Solithromycin, a ketolide/macrolide antibiotic, has recently been reported to be free of the expected QT-prolonging effect of macrolides. It appears that its keto substitution provides a structural basis for this observation, as the other two tested ketolides also have minimal QT effect.Among non-cardiovascular therapies, antimicrobials probably carry the greatest potential to cause cardiac arrhythmias. This is a result of their propensity to bind to the delayed rectifier potassium channel, IKr, inducing QT prolongation and risk of torsades de pointes ventricular tachycardia, their frequent interference with the metabolism of other QT prolongers and their susceptibility to metabolic inhibition by numerous commonly used drugs.Unfortunately, there is evidence that medical practitioners do not take account of the QT/arrhythmia risk of antimicrobials in their prescribing practices. Education on this topic is sorely needed. When a macrolide is indicated, a ketolide should be considered in patients with a QT risk.
Solithromycin, a ketolide/macrolide antibiotic, has recently been reported to be free of the expected QT-prolonging effect of macrolides. It appears that its keto substitution provides a structural basis for this observation, as the other two tested ketolides also have minimal QT effect.Among non-cardiovascular therapies, antimicrobials probably carry the greatest potential to cause cardiac arrhythmias. This is a result of their propensity to bind to the delayed rectifier potassium channel, IKr, inducing QT prolongation and risk of torsades de pointes ventricular tachycardia, their frequent interference with the metabolism of other QT prolongers and their susceptibility to metabolic inhibition by numerous commonly used drugs.Unfortunately, there is evidence that medical practitioners do not take account of the QT/arrhythmia risk of antimicrobials in their prescribing practices. Education on this topic is sorely needed. When a macrolide is indicated, a ketolide should be considered in patients with a QT risk.
Authors: Matt Mason; Eric Gregory; Keith Foster; Megan Klatt; Sara Zoubek; Albert J Eid Journal: Open Forum Infect Dis Date: 2022-06-15 Impact factor: 4.423
Authors: Teresa Maria Creanza; Pietro Delre; Nicola Ancona; Giovanni Lentini; Michele Saviano; Giuseppe Felice Mangiatordi Journal: J Chem Inf Model Date: 2021-09-10 Impact factor: 6.162
Authors: Thomas M File; Elizabeth Alexander; Lisa Goldberg; Anita F Das; Christian Sandrock; Susanne Paukner; Gregory J Moran Journal: BMC Pulm Med Date: 2021-05-08 Impact factor: 3.317
Authors: Angelos Arfaras-Melainis; Andreas Tzoumas; Damianos G Kokkinidis; Maria Salgado Guerrero; Dimitrios Varrias; Xiaobo Xu; Luis Cerna; Ricardo Avendano; Cameron Kemal; Leonidas Palaiodimos; Robert T Faillace Journal: J Cardiovasc Dev Dis Date: 2021-05-13
Authors: Oscar Arturo Lozano-Cruz; José Víctor Jiménez; Antonio Olivas-Martinez; Edgar Ortiz-Brizuela; José Luis Cárdenas-Fragoso; Daniel Azamar-Llamas; Sergio Rodríguez-Rodríguez; Jorge Carlos Oseguera-Moguel; Joel Dorantes-García; Clemente Barrón-Magdaleno; Aldo C Cázares-Diazleal; Carla Marina Román-Montes; Karla María Tamez-Torres; Bernardo Alfonso Martínez-Guerra; Alfonso Gulias-Herrero; María Fernanda González-Lara; Alfredo Ponce-de-León-Garduño; David Kershenobich-Stalnikowitz; José Sifuentes-Osornio Journal: Front Pharmacol Date: 2021-06-03 Impact factor: 5.810